Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopamine modulation of oxytocin prosocial effects
2011-006302-28Phase 2Terminated
- Sponsor
- University of Parma
- Start
- Jun 2012
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin, sponsored by University of Parma. Started Jun 2012; status: terminated.
02
Drugs
oxytocin
Beyond the preview
Go deeper on 2011-006302-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006302-28.